OHSU patient Heather Boynton describes her experience with a rare anaplastic astrocyte tumor.

Gervais High School students kick-off the 20th annual Mr. and Miss Gervais pageant to raise funds for OHSU Doernbecher.

OHSU School of Nursing students in Klamath Falls recently learned about Type 1 diabetes from a fifth-grader with the condition.

“We can let them struggle, get nervous, make mistakes without any harm to patient,” says Nathan Selden, M.D., Ph.D., in a story about lifelike brain surgery simulators developed at OHSU.

OHSU Casey Eye Institute clinicians recently performed the first CRISPR gene editing procedure within the human body as part of a clinical trial to address a blindness-causing gene mutation.

An OHSU-led evidence review finds that new direct-acting antiviral therapies effectively target Hepatitis C with few side effects. Roger Chou, M.D., says: “The treatments are much better tolerated and much shorter than they used to be”.

Lynne Strasfeld, M.D., is quoted in a story about people with chronic illnesses staying home.

Katharine Zuckerman, M.D., M.P.H., says children who are racial or ethnic minorities are less likely to be diagnosed with autism than their white peers, even when they have a “severe presentation” of the condition.

A Journal of the American Heart Association study by Saket Sanghai, M.D., and others finds about a quarter of older atrial fibrillation patients receive inappropriately dosed direct-acting oral anticoagulants.

OHSU’s REKNEW lab is featured in an episode of Bloomberg TV’s Prognosis. The story follows OHSU patient, member of the REKNEW research team, Gregory Bieker as he trials RSVP Keyboard, a brain-computer interface technology that allows individuals with severe speech and physical impairments to communicate using brainwaves.